Better Health, Brighter Future
Positions & Guidelines
“Takeda-ism” (integrity, fairness, honesty, perseverance), the founding spirit cultivated over our 237-year history, serves as the basis for our actions and decisions as we put the patient at the centre and prioritise building a trusting relationship with society.
Positions
Taxation
Guidelines
Suppliers Code of Conduct
The foundation of Takeda’s sustainable procurement programme is Takeda’s Supplier Code of Conduct, which is a key document for communicating Takeda’s position on the performance standards suppliers are expected to work toward as a part of doing business with Takeda. Takeda has incorporated the Supplier Code of Conduct as part of its procurement-managed supplier qualification process and uses its risk assessment model to prioritise suppliers for further review.
Takeda expects suppliers to adhere to applicable legal requirements and aspire to meet the expectations contained in Takeda’s Supplier Code of Conduct.
Takeda intends to evaluate suppliers’ fulfillment of the principles contained in the Supplier Code of Conduct, and expects suppliers to cooperate, including remediating identified issues. Takeda will collaborate with suppliers committed to improving conditions or issues identified with the goal of managing risks and creating long-term, sustainable value.
Suppliers are asked to review the below Takeda Supplier Code, and acknowledge receipt of the Code as part of conducting business with Takeda.
UK Modern Slavery Act
The Modern Slavery Act 2015 requires manufacturers and retailers doing business in the UK which supply goods or services and have an annual turnover exceeding £36 million to disclose information regarding their policies to eradicate slavery and human trafficking from their supply chain and within their business.
Fiscal Year 2021 - Modern Slavery Act Statement: Takeda Pharmaceuticals AG and Takeda UK Limited
Fiscal Year 2018 - Modern Slavery Act Statement: Takeda Pharmaceuticals AG and Takeda UK Limited
Fiscal Year 2017 - Modern Slavery Act Statement: Takeda Pharmaceuticals AG and Takeda UK Limited
Fiscal Year 2016 - Modern Slavery Act Statement: Takeda UK Limited
EXA/GB/CORP/0123
Date of Preparation: April 2023